Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CVNA NASDAQ:WBA NASDAQ:WBA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCVNACarvana$359.82-0.3%$365.93$148.25▼$413.33$77.67B3.552.71 million shs2.48 million shsWBAWalgreens Boots Alliance$11.98$11.89$8.08▼$13.25$10.37B0.835.94 million shsN/AWBAWalgreens Boots Alliance$11.98$11.89$8.08▼$13.25$10.37B0.835.94 million shsN/AThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCVNACarvana-2.68%-8.75%-2.92%+4.28%+88.94%WBAWalgreens Boots Alliance0.00%0.00%0.00%+3.63%+31.94%WBAWalgreens Boots Alliance0.00%0.00%0.00%+3.63%+31.94%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCVNACarvana$359.82-0.3%$365.93$148.25▼$413.33$77.67B3.552.71 million shs2.48 million shsWBAWalgreens Boots Alliance$11.98$11.89$8.08▼$13.25$10.37B0.835.94 million shsN/AWBAWalgreens Boots Alliance$11.98$11.89$8.08▼$13.25$10.37B0.835.94 million shsN/AThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCVNACarvana-2.68%-8.75%-2.92%+4.28%+88.94%WBAWalgreens Boots Alliance0.00%0.00%0.00%+3.63%+31.94%WBAWalgreens Boots Alliance0.00%0.00%0.00%+3.63%+31.94%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCVNACarvana 2.75Moderate Buy$404.9412.54% UpsideWBAWalgreens Boots Alliance 1.73Reduce$10.15-15.28% DownsideWBAWalgreens Boots Alliance 1.73Reduce$10.15-15.28% DownsideCurrent Analyst Ratings BreakdownLatest WBA, CVNA, and WBA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/9/2025CVNACarvanaCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy10/6/2025CVNACarvanaZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy10/1/2025CVNACarvanaJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetHold ➝ Buy$385.00 ➝ $475.0010/1/2025CVNACarvanaJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$385.00 ➝ $475.009/27/2025CVNACarvanaWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)9/23/2025CVNACarvanaStephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$440.009/17/2025CVNACarvanaJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$415.00 ➝ $425.008/12/2025CVNACarvanaEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetIn-Line$365.00 ➝ $370.007/31/2025CVNACarvanaWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$390.00 ➝ $425.007/31/2025CVNACarvanaJMP SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Outperform$440.00 ➝ $460.00(Data available from 10/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCVNACarvana$13.67B5.66$2.13 per share168.84$6.47 per share55.61WBAWalgreens Boots Alliance$147.66B0.07$5.73 per share2.09$13.91 per share0.86WBAWalgreens Boots Alliance$147.66B0.07$5.73 per share2.09$13.91 per share0.86Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCVNACarvana$210M$3.9990.1870.831.183.46%40.57%6.60%10/29/2025 (Estimated)WBAWalgreens Boots Alliance-$8.64B-$7.29N/A8.211.42-4.07%17.66%2.22%10/21/2025 (Estimated)WBAWalgreens Boots Alliance-$8.64B-$7.29N/A8.211.42-4.07%17.66%2.22%10/21/2025 (Estimated)Latest WBA, CVNA, and WBA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/29/2025Q3 2025CVNACarvana$1.29N/AN/AN/A$5.04 billionN/A7/30/2025Q2 2025CVNACarvana$1.09$1.28+$0.19$1.28$4.54 billion$4.84 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCVNACarvanaN/AN/AN/AN/AN/AWBAWalgreens Boots AllianceN/AN/AN/AN/AN/AWBAWalgreens Boots AllianceN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCVNACarvana2.514.002.58WBAWalgreens Boots Alliance0.960.600.32WBAWalgreens Boots Alliance0.960.600.32Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCVNACarvana56.71%WBAWalgreens Boots Alliance58.59%WBAWalgreens Boots Alliance58.59%Insider OwnershipCompanyInsider OwnershipCVNACarvana17.12%WBAWalgreens Boots Alliance17.50%WBAWalgreens Boots Alliance17.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCVNACarvana17,400215.20 million178.36 millionOptionableWBAWalgreens Boots Alliance325,000865.56 million714.09 millionOptionableWBAWalgreens Boots Alliance325,000865.56 million714.09 millionOptionableWBA, CVNA, and WBA HeadlinesRecent News About These CompaniesBoots’ biggest problem might just be its billionaire ownerSeptember 30, 2025 | finance.yahoo.comCVS Health Gains as Revenue Grows, Dividend Remains Strong (WBA)...September 25, 2025 | marketbeat.comWalgreens Boots Alliance Concludes Public Trading Era with $10 Billion Take-Private DealSeptember 23, 2025 | aktiencheck.deAShould Walgreens Boots Alliance's (WBA) SEC Deregistration Drive a Shift in Investor Expectations?September 16, 2025 | finance.yahoo.comWalgreens Boots Alliance (WBA): Assessing Valuation Following Voluntary SEC Deregistration AnnouncementSeptember 13, 2025 | finance.yahoo.comElizabeth Warren Warns About The Walgreens Takeover, Saying 'Private Equity Has A Record Of Running Companies Into The Ground'September 6, 2025 | finance.yahoo.comConsumer Retail Stocks Q2 In Review: Walgreens (NASDAQ:WBA) Vs PeersSeptember 5, 2025 | msn.comElizabeth Warren Warns About The Walgreens Takeover, Saying 'Private Equity Has A Record Of Running Companies Into The Ground'September 5, 2025 | benzinga.comCVS, Walgreens restrict Covid shots amid unclear CDC policyAugust 31, 2025 | seekingalpha.comSycamore Acquires Walgreens, CareCentix Goes It AloneAugust 30, 2025 | homehealthcarenews.comHSycamore Partners completes acquisition of WalgreensAugust 29, 2025 | healthcarefinancenews.comHBoots becomes ‘standalone company’ after Walgreens Boots Alliance saleAugust 29, 2025 | cosmeticsbusiness.comCSycamore finalises acquisition of Walgreens Boots AllianceAugust 29, 2025 | finance.yahoo.comSycamore Partners Completes Acquisition of Walgreens Boots AllianceAugust 28, 2025 | uk.finance.yahoo.comSycamore Partners closes acquisition of Walgreens, splits into 5 standalone companiesAugust 28, 2025 | fiercehealthcare.comFSycamore Completes Acquisition of Walgreens Boots AllianceAugust 28, 2025 | progressivegrocer.comPSycamore completes take-private buyout of retail pharmacy chain Walgreens Boots AllianceAugust 28, 2025 | pehub.comSycamore Completes Acquisition of Walgreens Boots Alliance, Forms 5 CompaniesAugust 28, 2025 | pymnts.comSycamore Completes Acquisition of Walgreens Boots Alliance, Forms 5 CompaniesAugust 28, 2025 | pymnts.comM&A News: Walgreens Boots Alliance (WBA) Is Now a Private CompanyAugust 28, 2025 | tipranks.comWalgreens names retail veteran Mike Motz as CEO after Sycamore takes chain privateAugust 28, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeWBA, CVNA, and WBA Company DescriptionsCarvana NYSE:CVNA$359.82 -1.09 (-0.30%) Closing price 03:59 PM EasternExtended Trading$359.50 -0.32 (-0.09%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Carvana Co., together with its subsidiaries, operates an e-commerce platform for buying and selling used cars in the United States. Its platform allows customers to research and identify a vehicle; inspect it using company's 360-degree vehicle imaging technology; obtain financing and warranty coverage; purchase the vehicle; and schedule delivery or pick-up from their desktop or mobile devices. The company also operates auction sites. The company was founded in 2012 and is based in Tempe, Arizona.Walgreens Boots Alliance NASDAQ:WBAWalgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.Walgreens Boots Alliance NASDAQ:WBAWalgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally AI Meets Nuclear: Palantir’s Role in Energy Expansion Buy the Dip? Zillow’s Profit Comeback Meets Market Pressure Adobe Launches Premiere Pro on iPhone, Upside Ahead? Rocket Lab: A Space Giant Hitting New Highs—Time to Chase? After AI Hyperscaler Deal, Is Aehr Test Systems Stock on Sale? Why Archer Aviation Stock Is Soaring—And What Comes Next Lithium Americas: Why This 31% Rally Is More Than Just a Headline Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
